上海市9~14岁女孩免费接种国产二价HPV疫苗的可行性

Feasibility of Free Vaccination with the Domestic Bivalent HPV Vaccine for Girl Aged 9-14 Years in Shanghai

宫颈癌是全球女性常见的第四大恶性肿瘤,已成为全球公共卫生问题。接种HPV疫苗是预防HPV感染和宫颈癌的有效手段之一。目前,HPV疫苗未纳入我国免疫规划程序,上海市9~45岁女性HPV疫苗接种率不到5%。二价国产疫苗具有良好的安全性和有效性,为9~14岁女孩接种2剂次国产二价HPV疫苗具有最佳的接种成本效益。为达到世界卫生组织“加速消除宫颈癌全球战略”中在2030年前实现15岁以下女孩HPV疫苗接种率达到90%以上的目标,在上海市9~14岁女孩中免费接种国产二价HPV疫苗是一项紧迫且可行的政府民生实事项目。

Cervical cancer has become a global public health problem.It is the fourth most common cancer in women.Vaccination is an effective measure against HPV infection and to reduce cervical cancer incidence.At present,HPV vaccine is not included in China's immunization program,and the coverage of HPV vaccine among women aged 9-45 in Shanghai is less than 5%.It is the best cost-effectiveness to administer 2 doses of the domestic bivalent HPV vaccine for girls aged 9-14 years.In order to achieve the goal of more than 90%girls under 15 years of age receiving HPV vaccine in the Global Strategy for Accelerating the Elimination of Cervical Cancer by 2030,it is an urgent and practical goverment project for improving people’s livelihood to receive free domestic bivalent HPV vaccines among girls aged 9-14 in Shanghai.